On June 17, 2013, the Company updated its corporate presentation materials on its website. The updated presentation, which is available on the “Events and Presentations” page on the Company’s website at http://ir.catalystpharma.com/events.cfm, provides the most updated information about the status of the Company’s Phase III clinical trial evaluating Firdapse™ for the treatment of Lambert-Eaton Myasthenic Syndrome.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.